The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
The changing and dynamic epidemiology of meningococcal disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Popovic, T., & Hughes, J. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441807 · Cited by 1,169
Global epidemiology of meningococcal disease
Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 755
Self-citationCohn, A. C., MacNeil, J. R., Harrison, L. H., Hatcher, C., Theodore, J., Schmidt, M., Pondo, T., Arnold, K. E., Baumbach, J., Bennett, N., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649209 · Cited by 345 · cited 1×
“28 per 00,000 in 2009 [56,70].”
Self-citationOSTER, P., LENNON, D., OHALLAHAN, J., MULHOLLAND, K., REID, S., & MARTIN, D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.063 · Cited by 271
Mayer, L. W., Reeves, M. W., Al‐Hamdan, N., Sacchi, C. T., Taha, M., Ajello, G. W., Schmink, S. E., Noble, C. A., Tondella, M. L. C., Whitney, A. M., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340414 · Cited by 227
Campbell, H., Andrews, N., Borrow, R., Trotter, C., & Miller, E. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00529-09 · Cited by 213
Review of Meningococcal Group B Vaccines
Granoff, D. M. (2010) · Clinical Infectious Diseases · doi:10.1086/648966 · Cited by 189
Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
Sow, S. O., Okoko, B. J., Diallo, A., Viviani, S., Borrow, R., Carlone, G., Tapia, M., Akinsola, A. K., Arduin, P., Findlow, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003812 · Cited by 178
Trotter, C. L., Gay, N. J., & Edmunds, W. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi160 · Cited by 177
EPIDEMIOLOGIC FEATURES OF MENINGOCOCCAL DISEASE
Rosenstein, N. E., Perkins, B. A., Stephens, D. S., et al. (2001) · Cited by 174
(2004) · World Atlas of Epidemic Diseases · doi:10.1201/b13526-11 · Cited by 164
LaForce, F. M., Ravenscroft, N., Djingarey, M. H., & Viviani, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.062 · Cited by 151
de Greeff, S. C., de Melker, H. E., Spanjaard, L., Schouls, L. M., & ENDE, A. V. D. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000195594.41449.c6 · Cited by 138
Sacchi, C. T., Fukasawa, L. O., Gonçalves, M. G., Salgado, M. M., Shutt, K. A., Carvalhanas, T. R. M. P., Ribeiro, A. F., Kemp, B., Gorla, M. C., Albernaz, R. K. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020675 · Cited by 124
Self-citationEffectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand
Arnold, R., Galloway, Y., McNicholas, A., & O’Hallahan, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.120 · Cited by 113
A Prospective Study of the Effectiveness of the New Zealand Meningococcal B Vaccine
Kelly, C., Arnold, R., Galloway, Y., & O'Hallahan, J. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm147 · Cited by 109
Harrison, L. H., Shutt, K. A., Schmink, S. E., Marsh, J. W., Harcourt, B. H., Wang, X., Whitney, A. M., Stephens, D. S., Cohn, A. C., Messonnier, N. E., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/651505 · Cited by 99
Self-citationvon Gottberg, A., du Plessis, M., Cohen, C., Prentice, E., Schrag, S. J., de Gouveia, L., Coulson, G., de Jong, G., Klugman, K. P., & Group for Enteric, R. A. M. D. S. I. S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/525260 · Cited by 98
Vaccine Preventable Diseases in Australia, 2005 to 2007
Chiu, C., Dey, A., Wang, H., Menzies, R., Deeks, S. L., Mahajan, D., Macartney, K. K., Brotherton, J. M. L., Jardine, A., Quinn, H., et al. (2010) · Communicable Diseases Intelligence · doi:10.33321/cdi.2010.34.48 · Cited by 94
Self-citationChronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso
Decosas, J., & Koama, J. B. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00455-3 · Cited by 94
Sáfadi, M. A. P., & Cintra, O. A. L. (2010) · Neurological Research · doi:10.1179/016164110x12644252260754 · Cited by 89
Self-citationEpidemic group C meningococcal meningitis in Upper Volta, 1979.
Broome, C. V., Rugh, M. A., Yada, A., Giat, L., Giat, H., Zeltner, J. M., Sanborn, W. R., & Fraser, D. W. (1983) · Europe PMC (PubMed Central) · Cited by 83
Oster, P., O’Hallahan, J., Aaberge, I. S., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.023 · Cited by 81
Cohen, C., Singh, E., Wu, H. M., Martin, S. W., de Gouveia, L., Klugman, K. P., Meiring, S. T., Govender, N. P., & von Gottberg, A. (2010) · AIDS · doi:10.1097/qad.0b013e32833a2520 · Cited by 78
Carriage of Meningococci by University Students, United Kingdom
Ala’Aldeen, D. A. A., Oldfield, N. J., Bidmos, F. A., Abouseada, N. M., Ahmed, N. W., Turner, D. P. J., Neal, K. R., & Bayliss, C. D. (2011) · Emerging infectious diseases · doi:10.3201/eid1709.101762 · Cited by 77
Fransen, F., Heckenberg, S. G. B., Hamstra, H.-J., Feller, M., Boog, C. J. P., van Putten, J. P. M., van de Beek, D., ENDE, A. V. D., & van der Ley, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000396 · Cited by 77
Annual report of the Australian Meningococcal Surveillance Programme, 2007.
TAPSALL, J. W. (2008) · PubMed · Cited by 77
The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba
Rodríguez, A. E. P., Dickinson, F., Baly, A., & Martínez, R. (1999) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02761999000400002 · Cited by 76
The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada
Bettinger, J. A., Scheifele, D. W., Saux, N. L., Halperin, S. A., Vaudry, W., & Tsang, R. S. W. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819040e7 · Cited by 76
Self-citationMeningococcal disease in Asia: an under-recognized public health burden
Vyse, A., Wolter, J. M., CHEN, J., et al. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811000574 · Cited by 76
Annual report of the Australian Meningococcal Surveillance Programme 1996
Australian Meningococcal Surveillance Programme, & TAPSALL, J. W. (1997) · Communicable Diseases Intelligence · doi:10.33321/cdi.1997.21.44 · Cited by 74
Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009
Ladhani, S. N., Lucidarme, J., Newbold, L. S., Gray, S. J., Carr, A. D., Findlow, J., Ramsay, M. E., Kaczmarski, E. B., & Borrow, R. (2012) · Emerging infectious diseases · doi:10.3201/eid1801.110901 · Cited by 71
Self-citationBidmos, F. A., Neal, K. R., Oldfield, N. J., Turner, D. P. J., Ala’Aldeen, D. A. A., & Bayliss, C. D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01322-10 · Cited by 70
Parkinson, A. J., Bruce, M. G., & Zulz, T. (2008) · Emerging infectious diseases · doi:10.3201/eid1401.070717 · Cited by 64
Meningococcal glycoconjugate vaccines
Gasparini, R., & Panatto, D. (2011) · Human Vaccines · doi:10.4161/hv.7.2.13717 · Cited by 62
Early Estimate of the Effectiveness of Quadrivalent Meningococcal Conjugate Vaccine
MacNeil, J. R., Cohn, A. C., Zell, E. R., Schmink, S. E., Miller, E. R., Clark, T. A., & Messonnier, N. E. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31820a8b3c · Cited by 58
Efron, A., Sorhouet, C., Salcedo, C., Abad, R., Regueira, M., & Vázquez, J. A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-08 · Cited by 54
Effectiveness of Serogroup C Meningococcal Conjugate Vaccine
Wals, P. D., Deceuninck, G., Lefebvre, B., Boulianne, N., & Serres, G. D. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31820e8638 · Cited by 52
Serogroup Y Meningococcal Disease, Colombia
Agudelo, C. I., Sanabria, O. M., & Ovalle, M. V. (2008) · Emerging infectious diseases · doi:10.3201/eid1406.071357 · Cited by 50
Hedberg, S. T., Törös, B., Fredlund, H., Olcén, P., & Mölling, P. (2011) · Eurosurveillance · doi:10.2807/ese.16.23.19885-en · Cited by 46
Trotter, C. L., Ramsay, M. E., Gray, S., Fox, A., & Kaczmarski, E. B. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70584-9 · Cited by 46
Self-citationRoca, A., Bassat, Q., Morais, L., Machevo, S., Sigaúque, B., O’Callaghan, C., Nhampossa, T., Letang, E., Mandomando, I., Nhalungo, D. A., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596497 · Cited by 46
Kinlin, L. M., Jamieson, F., Brown, E. M., Brown, S., Rawte, P., Dolman, S., Drews, S. J., & Fisman, D. N. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.026 · Cited by 44
NAIR, D., Dawar, R., Deb, M., Capoor, M. R., SINGAL, S., UPADHAYAY, D. J., Aggarwal, P., Das, B., & Samantaray, J. C. (2008) · Epidemiology and Infection · doi:10.1017/s0950268808001398 · Cited by 44
Hausdorff, W. P., Hajjeh, R. A., Almazrou, A., Shibl, A. M., & Soriano‐Gabarró, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.11.018 · Cited by 43
A doença meningocócica em São Paulo, Brasil, no século XX: características epidemiológicas
de Moraes, J. C., & Barata, R. B. (2005) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2005000500019 · Cited by 42
Lévy, C., Taha, M., Weil-Olivier, C., Quinet, B., Lécuyer, A., Alonso, J. M., Aujard, Y., Bingen, É., & Cohen, R. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181d3ce32 · Cited by 38
Meningococcal disease and vaccination in North America
Pollard, A. J., & Scheifele, D. W. (2001) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2001.00679.x · Cited by 33
Ibarz-Pavón, A. B., Morais, L., Sigaúque, B., Mandomando, I., Bassat, Q., Nhacolo, A., Quintó, L., Soriano‐Gabarró, M., Alonso, P. L., & Roca, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019717 · Cited by 26
Fransen, F., Hamstra, H.-J., Boog, C. J. P., van Putten, J. P. M., van den Dobbelsteen, G. P. J. M., & van der Ley, P. (2010) · Infection and Immunity · doi:10.1128/iai.01311-09 · Cited by 26
[An epidemic of meningococcal infection in Vietnam (southern provinces)].
Oberti, J., Hoi, N. T., Caravano, R., Tan, C. M., & Roux, J. (1981) · Europe PMC (PubMed Central) · Cited by 24
Iser, B. P. M., Lima, H. C. A., de Moraes, C., ALMEIDA, R. P. A. D., Watanabe, L. T., Alves, S. L. A., de Lemos, A. P. S., Gorla, M. C., Gonçalves, M. G., SANTOS, D. A. D., et al. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811001610 · Cited by 24
Emergence and disappearance of W135 meningococcal disease
Wilder‐Smith, A., Chow, A. L., & Goh, K. T. (2009) · Epidemiology and Infection · doi:10.1017/s095026880999104x · Cited by 24
Acute Bacterial Meningitis at the 'Complexe Pediatrique' of Bangui, Central African Republic
Bercion, R., Bobossi-Serengbé, G., Gody, J. C., Beyam, N., Manirakiza, A., & Faou, A. L. (2007) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmm075 · Cited by 24
Granoff, D. M., Pelton, S. I., & Harrison, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00029-x · Cited by 24
Self-citationAcute childhood bacterial meningitis in Luanda, Angola
Pelkonen, T., Roine, I., Monteiro, L., Simões, M. J., Anjos, E., Pelerito, A., Pitkäranta, A., Bernardino, L., & Peltola, H. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540802262091 · Cited by 23
Jackson, C., LENNON, D. R., Wong, S., Yan, J., STEWART, J. M., Reid, S., Oster, P., Ypma, E., & Martin, D. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2009.180596 · Cited by 21
B:2a:P1.5 Meningococcal Strains Likely Arisen from Capsular Switching Event Still Spreading in Spain
Castilla, J., Vázquez, J. A., Salcedo, C., Cenoz, M. G., García-Irure, J. J., Torroba, L., Beristain, X., Abad, R., & Barricarte, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01495-08 · Cited by 21
Epidemiology and Meningococcal Serogroup Distribution in the United States
Hershey, J. H., & Hitchcock, W. P. (2010) · Clinical Pediatrics · doi:10.1177/0009922809347797 · Cited by 21
Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection
Saux, N. L., Bettinger, J. A., Wootton, S. H., et al. (2009) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2009/871071 · Cited by 19
Self-citationBacterial Meningitis andHaemophilus influenzaeType b Conjugate Vaccine, Malawi
McCormick, D. W., & MOLYNEUX, E. M. (2011) · Emerging infectious diseases · doi:10.3201/eid1704.101045 · Cited by 18
MODERN TRENDS IN MORTALITY FROM MENINGOCOCCAL DISEASE IN AUSTRALIA
Simpkins, D., Wood, N., Jelfs, J., et al. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181accde8 · Cited by 17
Self-citationNi, J. D., Jin, Y., Dai, B., Wang, X. P., Liu, D. Q., Chen, X., Zheng, Y., & Ye, D. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.065680 · Cited by 15
Pollard, A. J., & Finn, A. H. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00127-6 · Cited by 10
Etude d'une épidémie de méningococcie au Viet Nam (provinces du sud)]
Oberti, J., Nguyen, N. H., Caravano, R., et al. (1981) · Bulletin of the World Health Organization · Cited by 9
Research works printed but not linked: 32
- el-Akkad, 1969, Epidemiology of cerebrospinal meningitis in Egypt during the last 50 years, J Egypt Public Health Assoc, 44, 260
- Nakhla, 2005, The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt, Vaccine, 23, 3288, 10.1016/j.vaccine.2005.01.084 · doi:10.1016/j.vaccine.2005.01.084
- Collard, 2010, Increase in Neisseria meningitidis serogroup W135, Niger, 2010 [letter], Emerg Infect Dis, 16, 1496, 10.3201/eid1609.100510 · doi:10.3201/eid1609.100510
- Mutonga, 2009, Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005–2006, Am J Trop Med Hyg, 80, 619, 10.4269/ajtmh.2009.80.619 · DOI
- WHO, 2006, Meningococcal disease, Uganda – update, Wkly Epidemiol Rec, 81, 62
- Sinclair, 2010, The epidemiology of meningocccal disease in India, Trop Med Int Health, 15, 1421, 10.1111/j.1365-3156.2010.02660.x · doi:10.1111/j.1365-3156.2010.02660.x
- Whittle, 1975, Group-C meningococcal meningitis in the northern savanna of Africa, Lancet, 1, 1377, 10.1016/S0140-6736(75)92281-3 · doi:10.1016/s0140-6736(75)92281-3
- Hu, 1991, Study on periodically prevalent feature for epidemic cerebrospinal meningitis in China, Chin J Epidemiol, 12, 136
- Hossain, 2009, Short report: increasing isolations of Neisseria meningitidis serogroup A from blood and cerebrospinal fluid in Dhaka, Bangladesh, 1999–2006, Am J Trop Med Hyg, 80, 615, 10.4269/ajtmh.2009.80.615 · doi:10.4269/ajtmh.2009.80.615
- Patel, 1926, Cerebrospinal fever in Bombay. A study of 170 consecutive cases during the years 1921–1924, Lancet, 11, 539, 10.1016/S0140-6736(01)27828-3 · doi:10.1016/s0140-6736(01)27828-3
- Australian Government Department of Health and Ageing, 2010, Communicable Diseases Surveillance: National Notifiable Diseases Surveillance System, Commun Dis Intell, 34, 214
- Patel, 1993, Epidemic meningococcal meningitis in central Australia, 1987–1991, Med J Aust, 158, 336, 10.5694/j.1326-5377.1993.tb121793.x · doi:10.5694/j.1326-5377.1993.tb121793.x
- Martin, 1998, New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4, J Inf Dis, 177, 497, 10.1086/517385 · doi:10.1086/517385
- Ishola D, Borrow R, Findlow H, Trotter C, Ramsay M. P 068. Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England, a decade after vaccine introduction (pages 174–5). The 11th European Meningococcal Group Meeting (EMGM) Congress 2011: Ljubljana, Slovenia, Abstract available at: <http://emgm.eu/meetings/emgm2011/abstracts.pdf> [accessed 04.10.11].
- Caugant DA, Løvoll Ø, Blystad H. P040. Meningococcal disease in Norway, 2009–2010: emergence of serogroup Y. EMGM (Pages 117–8). The 11th European Meningococcal Group Meeting (EMGM) Congress 2011: Ljubljana, Slovenia. Abstract available at: <http://emgm.eu/meetings/emgm2011/abstracts.pdf> [accessed 04.10.11].
- Vainio A, Toropainen M, Kuusi M, Virolaine A. P 037. Characteristics of invasive meningococcal serogroup Y isolates in Finland, 1995-2010 (Pages 111–2). The 11th European Meningococcal Group Meeting (EMGM) Congress 2011: Ljubljana, Slovenia. Abstract available at: <http://emgm.eu/meetings/emgm2011/abstracts.pdf> [accessed 04.11.11].
- Trotter C, Findlow H, Chadha H, Townsend K, Thompson D, Mabey L, et al. P 036. Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009 (pages 109–10). The 11th European Meningococcal Group Meeting (EMGM) Congress 2011: Ljubljana, Slovenia, Abstract available at: <http://emgm.eu/meetings/emgm2011/abstracts.pdf> [accessed 04.11.11]. · doi:10.1128/cvi.05515-11
- Advisory Committee on Immunization Practices (ACIP), 2011, Updated recommendations for use of meningococcal conjugate vaccines, 2010, MMWR Morb Mortal Wkly Rep, 60, 72
- Advisory Committee on Immunization Practices (ACIP), 2011, Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease, 2011, MMWR Morb Mortal Wkly Rep, 60, 1018
- Watkins, 2006, Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003, Can Commun Dis Rep, 32, 97
- Varughese, 1989, Meningococcal disease in Canada. Surveillance summary to 1987, Can Dis Wkly Rep, 15, 89
- National Advisory Committee on Immunization, 2009, Update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS), Can Commun Dis Rep, 36, 1
- Deeks, 1997, Surveillance of invasive meningococcal disease in Canada: 1995–1996, Can Commun Dis Rep, 23, 121
- 2009, Case definitions for communicable diseases under national surveillance, Can Commun Dis Rep, 35, 1
- Scheifele, 2009, IMPACT after 17 years: lessons learned about successful networking, Paediatr Child Health, 14, 33, 10.1093/pch/14.1.33 · doi:10.1093/pch/14.1.33
- Bettinger, 2010, The epidemiology of serogroup B meningococcal infections in Canada: IMPACT 2002–2009 [abstract], Can J Infect Dis Med Microbiol, 21, 179
- Law, 2006, Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19), J Clin Microbiol, 44, 2743, 10.1128/JCM.00601-06 · doi:10.1128/jcm.00601-06
- Tsang, 2002, Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada: January 1, 1999 to June 30, 2001, Can J Infect Dis, 13, 391, 10.1155/2002/891673 · doi:10.1155/2002/891673
- Tsang, 2007, Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada, J Clin Microbiol, 45, 1753, 10.1128/JCM.02134-06 · DOI
- Lemos, 2006, Phenotypic characterization of Neisseria meningitidis strains isolated from invasive disease in Brazil from 1990 to 2001, J Med Microbiol, 55, 751, 10.1099/jmm.0.46451-0 · doi:10.1099/jmm.0.46451-0
- Pírez, 2004, Control de un brote epidémico de enfermedad meningocócica por N. meningitidis serogrupo B, Rev Med Uruguay, 20, 92
- Chacon-Cruz, 2011, Surveillance for invasive meningococcal disease in children, US-Mexico border, 2005–2008, Emerg Infect Dis, 17, 543, 10.3201/eid1703.101254 · doi:10.3201/eid1703.101254
Cited by
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Abyu, G. Y., Ahmed, M. B., Aichour, A. N., Aichour, I., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30299-5 · Cited by 2,275
Effect of vaccines on bacterial meningitis worldwide
McIntyre, P. B., O'Brien, K. L., Greenwood, B., & van de Beek, D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61187-8 · Cited by 326
Self-citationDing, C., Wu, Y., Chen, X., Chen, Y., Wu, Z., Lin, Z., Kang, D., Fang, W., & Chen, F. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.952161 · Cited by 311
Borrow, R., Alarcón, P., Carlos, J., Caugant, D. A., Christensen, H., Debbag, R., De Wals, P., Echániz-Aviles, G., Findlow, J., Head, C., et al. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1258308 · Cited by 269
Self-citation
Metadata
- Authors
- Halperin, S. A., Bettinger, J. A., Greenwood, B., Harrison, L. H., Jelfs, J., Ladhani, S. N., McIntyre, P., Ramsay, M. E., & Sáfadi, M. A. P.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 30
- Pages
- B26-B36
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2013735067
- Cited by
- 307
- References
- 65
- FWCI
- 21.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.